High-throughput molecular assays for inclusion in personalised oncology trials - State-of-the-art and beyond
J Intern Med (in press)
DOI 10.1111/joim.13785, PubMed 38698538
A comprehensive characterization of the spectrum of MUTYH germline pathogenic variants in Latin America
Fam Cancer (in press)
DOI 10.1007/s10689-024-00382-3, PubMed 38687439
Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations
JAMA Oncol, 10 (4), 484-492
DOI 10.1001/jamaoncol.2023.6937, PubMed 38421677
More publications